A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial – the PRADA trial

[1]  D. Margolis,et al.  Epidemiology of atopic dermatitis in adults: Results from an international survey , 2018, Allergy.

[2]  A. Litonjua,et al.  Low Maternal Prenatal 25-Hydroxyvitamin D Blood Levels Are Associated with Childhood Atopic Dermatitis. , 2017, The Journal of investigative dermatology.

[3]  Soo-Nyung Kim,et al.  Vitamin D Status and Efficacy of Vitamin D Supplementation in Atopic Dermatitis: A Systematic Review and Meta-Analysis , 2016, Nutrients.

[4]  J. Silverberg,et al.  Persistence of atopic dermatitis (AD): A systematic review and meta-analysis. , 2016, Journal of the American Academy of Dermatology.

[5]  Stephan Weidinger,et al.  Atopic dermatitis , 2016, The Lancet.

[6]  J. Chae,et al.  Vitamin D Status and Its Association with the SCORAD Score and Serum LL-37 Level in Korean Adults and Children with Atopic Dermatitis , 2015, Annals of dermatology.

[7]  J. Schmitt,et al.  Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME) , 2014, The British journal of dermatology.

[8]  M. Mittleman,et al.  Exchangeability in the case-crossover design. , 2014, International journal of epidemiology.

[9]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. , 2014, Journal of the American Academy of Dermatology.

[10]  Thomas Bieber,et al.  Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? , 2014, The Journal of allergy and clinical immunology.

[11]  M. Augustin,et al.  Willingness to pay and quality of life in patients with atopic dermatitis , 2014, Archives of Dermatological Research.

[12]  P. Spuls,et al.  Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research , 2014, The British journal of dermatology.

[13]  C. Flohr,et al.  New insights into the epidemiology of childhood atopic dermatitis , 2014, Allergy.

[14]  K. Ezzedine,et al.  [Atopic dermatitis severity and vitamin D concentration: a cross-sectional study]. , 2013, Annales de dermatologie et de venereologie.

[15]  J. Silverberg,et al.  Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. , 2013, The Journal of allergy and clinical immunology.

[16]  Gary K Grunwald,et al.  GLIMMPSE: Online Power Computation for Linear Models with and without a Baseline Covariate. , 2013, Journal of statistical software.

[17]  E. Vezir,et al.  Vitamin D Level in Children Is Correlated with Severity of Atopic Dermatitis but Only in Patients with Allergic Sensitizations , 2013, Pediatric dermatology.

[18]  T. Zuberbier,et al.  Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. , 2012, The Journal of allergy and clinical immunology.

[19]  A. Sheikh,et al.  Systematic Review of Epidemiological Studies , 2022 .

[20]  S. Jariwala,et al.  The role of vitamin D in the immunopathogenesis of allergic skin diseases , 2012, Allergy.

[21]  M. Pistiner.  Correlation Between Serum 25-Hydroxyvitamin D Levels and Severity of Atopic Dermatitis in Children , 2011, Pediatrics.

[22]  J. Ware,et al.  Pragmatic trials--guides to better patient care? , 2011, The New England journal of medicine.

[23]  D. Price,et al.  Leukotriene antagonists as first-line or add-on asthma-controller therapy. , 2011, The New England journal of medicine.

[24]  J. Schmitt,et al.  Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta‐analysis of randomized controlled trials , 2011, The British journal of dermatology.

[25]  M. Maclure.  Explaining pragmatic trials to pragmatic policy-makers , 2009, Canadian Medical Association Journal.

[26]  M. Bosseila,et al.  Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis. , 2009, Journal of dermatological science.

[27]  C. Furberg,et al.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. , 2009, Journal of clinical epidemiology.

[28]  P. Elias,et al.  Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. , 2008, The Journal of investigative dermatology.

[29]  T. Bieber,et al.  Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment , 2008, Allergy.

[30]  T. Bieber,et al.  Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment , 2008, Allergy.

[31]  Sebastian Schneeweiss,et al.  Use of the case-crossover design to study prolonged drug exposures and insidious outcomes. , 2004, Annals of epidemiology.

[32]  R. Damstra,et al.  Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study , 2003, BMJ : British Medical Journal.

[33]  Icmje Icmje,et al.  UNIFORM REQUIREMENTS FOR MANUSCRIPTS SUBMITTED TO BIOMEDICAL JOURNALS , 2000 .

[34]  F. Davidoff,et al.  Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. , 1997, Annals of internal medicine.

[35]  Lois Ann Colaianni,et al.  Uniform Requirements for Manuscripts Submitted to Biomedical Journals , 1991, The Medical journal of Australia.

[36]  E. Simpson,et al.  Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. , 2011, The Journal of investigative dermatology.

[37]  Thomas Bieber,et al.  Atopic dermatitis. , 2008, The New England journal of medicine.

[38]  M Maclure,et al.  Should we use a case-crossover design? , 2000, Annual review of public health.

[39]  H. Williams,et al.  Systematic review of treatments for atopic eczema. , 2000, Health technology assessment.

[40]  D. Strachan,et al.  Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. , 1999, The Journal of allergy and clinical immunology.

[41]  Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. , 1988, Southern medical journal.

[42]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.